JPS6129669B2 - - Google Patents
Info
- Publication number
- JPS6129669B2 JPS6129669B2 JP54079495A JP7949579A JPS6129669B2 JP S6129669 B2 JPS6129669 B2 JP S6129669B2 JP 54079495 A JP54079495 A JP 54079495A JP 7949579 A JP7949579 A JP 7949579A JP S6129669 B2 JPS6129669 B2 JP S6129669B2
- Authority
- JP
- Japan
- Prior art keywords
- serum
- plasma
- blood
- specific gravity
- chlorinated polybutene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Centrifugal Separators (AREA)
Description
【発明の詳細な説明】
本発明は容器内に採集された血液を遠心分離操
作によつて血清或いは血漿と血球とに分離する方
法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for separating blood collected in a container into serum or plasma and blood cells by centrifugation.
近年、臨床検査部門における血液成分の検査が
極めて重要視され、検査件数は増加の一途をたど
つている。その中で、血清学的検査等において
は、試料として血清或いは血漿のみを用いる項目
が多く、検査の為の前操作として、血清或いは血
漿と血球とを分離する事が必要である。この為、
従来は遠心分離操作のみりより、血球部分を沈殿
せしめた後、ビベツトにて吸い上げる方法で血清
或いは血漿を採取していた。しかしながら、この
方法は分離が不十分である上にたいへん手間がか
かり最近になつて、この血清或いは血漿の採取を
簡便かつ高収率で行なえるよう種々の方法が工夫
されるようになつた。その1つに試料血液中に血
清或いは血漿と血球との中間の比重を有する物質
を加え、遠心分離操作によつて該物質を両者の中
間に位置させて分離壁を形成せしめる方法があ
る。この方法によれば、デカンテーシヨンのみに
より血清或いは血漿を分取する事が可能であり、
時間及び労力の削減を図り得るが他方次の様な欠
点も有していた。 In recent years, testing of blood components in clinical laboratory departments has become extremely important, and the number of tests conducted has continued to increase. Among these, many serological tests use only serum or plasma as a sample, and it is necessary to separate serum or plasma from blood cells as a pre-test procedure. For this reason,
Conventionally, serum or plasma has been collected by centrifuging to precipitate blood cells and then sucking it up in a bivet. However, this method provides insufficient separation and is very time-consuming, and recently various methods have been devised to allow serum or plasma to be collected easily and with high yield. One method is to add a substance having a specific gravity intermediate between that of serum or plasma and blood cells to a blood sample, and use centrifugation to position the substance between the two to form a separation wall. According to this method, it is possible to separate serum or plasma only by decantation,
Although it is possible to reduce time and labor, it also has the following drawbacks.
即ちこの代表的な方法としては、血清或いは血
漿分離材としてスチレンビーズを用いる方法と、
シリコーンとシリカとの混合物からなるチキソト
ロピー性を示す組成物を用いる方法とが知られて
いるが、前者は、分離終了後に衝撃等によつて不
測の力が加わると形成されていたスチレンビーズ
からなる分離壁が破壊され、採血用試験管等をそ
のまま輸送することができないという欠点を有
し、更に分離壁が粉子の集結体であり連続構造で
はない為血球の血清或いは血漿への混入が生じた
りする等分離精度が低いという欠点も有してい
た。又後者は、輸送・分取・分離性能の面では一
般に前者よりも優れているものの分離材がチキソ
トロピー性を有するが故に、遠心力によつて良好
に流動性を示す迄に時間を要し遠心分離条件によ
つては分離壁が充分均一に形成されずに結果的に
は分離がシヤープに行われない場合があり、他方
スピツツ管等の容器に一定量分注する操作がむず
かしく作業能率が劣ることに加えて、これ等の作
業中に空気を巻き込むと発生した気泡は真空採血
管の真空化工程に於ても解消し難く、採血管の真
空度を低減させたり、バラツキを生じさせたり
し、採血性能が低下し易く、、さらに成分面から
みると、分離に充分な量のシリコーンオイルとチ
キソトロピー性を高度に付与出来る量のシリカと
は、シリコーンオイルが血液凝固速度を遅らせ検
査時間の短縮を妨げ、シリカが血液中の検査対象
成分を吸着し検査精度を狂わす等の問題点を有
し、更にこれ等原料が極めて高価である点も工業
的価値を低めているのであつた。 That is, typical methods include a method using styrene beads as a serum or plasma separation material;
A method using a thixotropic composition consisting of a mixture of silicone and silica is known, but the former consists of styrene beads that are formed when an unexpected force is applied, such as by an impact, after separation is completed. This method has the disadvantage that the separation wall is destroyed, making it impossible to transport test tubes for blood collection, etc. Furthermore, since the separation wall is an aggregate of powder and is not a continuous structure, blood cells may be mixed into serum or plasma. It also had the disadvantage of low equi-separation accuracy. Although the latter is generally superior to the former in terms of transportation, fractionation, and separation performance, because the separation material has thixotropic properties, it takes time to show good fluidity due to centrifugal force. Depending on the separation conditions, the separation wall may not be formed sufficiently uniformly, resulting in poor separation, and on the other hand, dispensing a fixed amount into a container such as a Spitz tube may be difficult, resulting in poor work efficiency. In addition, air bubbles generated when air is drawn in during these operations are difficult to eliminate during the vacuuming process of the vacuum blood collection tube, reducing the degree of vacuum in the blood collection tube and causing variations. , Blood collection performance tends to deteriorate.Furthermore, from a component standpoint, the amount of silicone oil sufficient for separation and the amount of silica that can provide a high degree of thixotropy are important because silicone oil slows down the blood coagulation rate and shortens test time. However, the silica adsorbs the components to be tested in the blood, impairing the accuracy of the test.Furthermore, these raw materials are extremely expensive, reducing their industrial value.
本発明は上述の如き従来技術の欠点を解消し、
極めて効率よくしかも高濃度で血清或いは血漿を
血液から分離する新規な方法を提供するものにし
てその要旨は容器内に採集された血液を遠心分離
操作によつて血清或いは血漿と血球とに分離する
方法に於て、比重が1.026〜1.09であり静止時に
流動性を有するが液状シリコーンと相溶性に乏し
い塩素化ポリブテンと、比重が1.026〜1.09で且
つ上記塩素化ポリブテンより小さく、静止時に流
動性がないがチキソトロピー性を示す。液状シリ
コーンとチキソトロピー性付与剤とからなるゲル
状組成物との混合物を、容器内の血液と共存させ
て遠心分離操作を行うそとを特徴とする血清或い
は血漿分離方法に存する。 The present invention overcomes the drawbacks of the prior art as described above,
The present invention provides a new method for separating serum or plasma from blood with high efficiency and high concentration.The gist of the method is to separate blood collected in a container into serum or plasma and blood cells by centrifugation. In the method, chlorinated polybutene has a specific gravity of 1.026 to 1.09 and has fluidity when at rest, but has poor compatibility with liquid silicone, and chlorinated polybutene has a specific gravity of 1.026 to 1.09 and is smaller than the above chlorinated polybutene and has no fluidity when at rest. However, it exhibits thixotropic properties. A method for separating serum or plasma, characterized in that a mixture of liquid silicone and a gel composition comprising a thixotropic agent is allowed to coexist with blood in a container, and then centrifuged.
本発明に於て使用される塩素化ポリブテンは、
その比重が1.026〜1.09好ましくは1.03〜1.08であ
り静止時に流動性がある液状物であり、25℃に於
ける粘度が500〜2000000CPS、とくに1000〜
1000000CPSであるが好ましい。そして該塩素化
ポリブテンは液状シリコーンと相溶性に乏しい性
を有する。 The chlorinated polybutene used in the present invention is
It is a liquid substance with a specific gravity of 1.026 to 1.09, preferably 1.03 to 1.08, and is fluid at rest, and a viscosity of 500 to 2,000,000 CPS at 25°C, especially 1,000 to 1,000.
1000000CPS is preferred. The chlorinated polybutene has poor compatibility with liquid silicone.
本発明に於て使用されるゲル状組成物は、比重
が1.026〜1.09好ましくは、1.03〜1.08であり、上
記塩素化ポリブテンより比重が小さく、かつ、静
止時に流動性が認められないがチキソトロピー性
を示すもので、液状シリコーンとチキソトロピー
性付与剤からなるものである。チキソトロピー性
付与剤としては、シリカ、アルミナ、タルク、ベ
ントナイト、チタニア、ジルコニウム、アスベス
ト、カーボンブラツク等の粉粒状物が挙げられ、
ゲル状組成物は液状シリコーン例えばジメチルポ
リシロキサンに上記チキソトロピー性付与剤を加
えて混合し、添加量等によつて比重を調整するこ
とによつて用意される。なお、チキソトロピー性
付与剤を用いる際の留意点は、液状シリコーンに
混入された時に均一に分散し、その後の操作、例
えば粘性液状物との混合、容器への充填(分
注)、遠心分離操作等の間に液状シリコーンから
遊離したり、分散状態が不均一になつたりしない
ことである。 The gel composition used in the present invention has a specific gravity of 1.026 to 1.09, preferably 1.03 to 1.08, which is lower than that of the above-mentioned chlorinated polybutene, and has thixotropic properties although no flowability is observed at rest. It is composed of liquid silicone and a thixotropic agent. Examples of the thixotropic agent include powdery materials such as silica, alumina, talc, bentonite, titania, zirconium, asbestos, and carbon black.
The gel composition is prepared by adding the above-mentioned thixotropy imparting agent to a liquid silicone such as dimethylpolysiloxane, mixing the mixture, and adjusting the specific gravity depending on the amount added and the like. Note that when using a thixotropic agent, it is important to ensure that it is uniformly dispersed when mixed into liquid silicone, and that subsequent operations, such as mixing with a viscous liquid, filling (dispensing) into containers, and centrifugation operations, are important. During the process, the silicone should not be released from the liquid silicone, and the dispersion state should not become non-uniform.
前記塩素化ポリブテンとゲル状組成物は、血清
或いは血漿の分離に用いられるに際しは両者が混
合され、混合状態となされるのであるが、この混
合物においては、見かけ上は均一に混合していて
も全く相溶状態ではなく、遠心分離操作によつて
両者の比重差により、最終的には前者は下層に後
者は上層にはつきりと分離した構成で分離壁を形
成する。即ち塩素化ポリブテンと、上記ゲル状組
成物は遠心分離操作の初期には見かけ上均一に混
合している状態にあるが遠心分離操作が進行する
にしたがい、両者の比重差及び相溶性に乏しいこ
とにより最終的には分離壁がその上部は上記ゲル
状組成物、下部は塩素化ポリブテンからなる二層
で構成されるところに本発明の多くの作用効果を
奏する要素が存在するのである。 When the chlorinated polybutene and the gel composition are used to separate serum or plasma, they are mixed to form a mixed state. They are not in a compatible state at all, and due to the difference in specific gravity between the two by centrifugation, they eventually form a separation wall in which the former is in the lower layer and the latter is in the upper layer. That is, the chlorinated polybutene and the above-mentioned gel composition appear to be mixed uniformly at the beginning of the centrifugation operation, but as the centrifugation operation progresses, there is a difference in specific gravity and poor compatibility between the two. Therefore, the separation wall is finally composed of two layers, the upper part of which is made of the above-mentioned gel composition and the lower part of which is made of chlorinated polybutene, and this is where the elements that exhibit many of the functions and effects of the present invention are present.
ここで両者が混合状態にある時は、塩素化ポリ
ブテンの中に小さく分割された上記ゲル状組成物
が均一に分散する如くになされており、好ましく
はこの状態で、予め容器に収集された血液中に分
注され、遠心分離操作により、しだいに上記ゲル
状組成物の粒子が塩素化ポリブテン中を上昇し
て、ついには塩素化ポリブテン層の上面全体を覆
う状態で粒子相互が接続し一体化していくことに
より、遠心分離操作終了後には、流動性を示さな
い上記ゲル状組成物より成る層が分離壁の上部層
として形成され、この分離壁の下方には血球が位
置し、上方には血清或いは血漿が位置するのであ
る。 Here, when the two are in a mixed state, the above-mentioned gel composition divided into small pieces is uniformly dispersed in the chlorinated polybutene, and preferably in this state, blood collected in advance in a container is By centrifugation, the particles of the gel-like composition gradually rise through the chlorinated polybutene, and the particles eventually connect with each other and become integrated, covering the entire top surface of the chlorinated polybutene layer. As a result, after the centrifugation operation is completed, a layer made of the gel-like composition that does not exhibit fluidity is formed as an upper layer of the separation wall, and blood cells are located below the separation wall, and blood cells are located above the separation wall. Serum or plasma is located here.
本発明の着目すべき点を概括すると、塩素化ポ
リブテン又はゲル状組成物を単独で用いて血清或
いは血漿の分離を行う従来の方法の効果をそのま
ま保持しつつ、両組成物を本発明の要旨にて説明
した如く巧妙に組合せ配置させることにより、従
来方法の問題点を見事に解決した点にあると言え
よう。 To summarize the noteworthy points of the present invention, while maintaining the effects of the conventional method of separating serum or plasma using chlorinated polybutene or a gel composition alone, the present invention can combine both compositions. It can be said that the problems of the conventional method have been successfully solved by cleverly combining and arranging them as explained in .
本発明血清或いは血漿分離方法は比重が1.026
〜1.09であり静止時に流動性を有するが液状シリ
コーンと相溶性に乏しい塩素化ポリブテンと、比
重が1.026〜1.09で且つ上記塩素化ポリブテンよ
り小さく、静止時に流動性がないがチキソトロピ
ー性を示す液状シリコーンとチキソトロピー性付
与剤とからなるゲル状組成物との混合物を、容器
内の血液と共存させて遠心分離操作を行うので、
先ず第1の作用効果として、上記塩素化ポリブテ
ンと上記ゲル状組成物が前述の如き状態で混合さ
れているものは良好な流動性を具備しており、チ
キソトロピー性の優れたゲル状組成物を単独で使
用する場合に認められる問題点、例えば十分な流
動性を示すまでに時間を必要とする点、気泡を形
成し易く脱泡しにくい点、分注精度が低く作業能
率が悪い点等を解決出来るのみならず、ゲル状組
成物の使用量を低下させ得ることから、シリコー
ンが多いと起る血液凝固の遅延や、さらにはシリ
カが多いと起る検査精度の悪化を回避出来ること
や、液状シリコーンの使用量減少に伴いコスト面
での改善が出来ること等が挙げられる。 The serum or plasma separation method of the present invention has a specific gravity of 1.026.
~1.09 and has fluidity when at rest, but has poor compatibility with liquid silicone; and liquid silicone, which has a specific gravity of 1.026 to 1.09 and is smaller than the above chlorinated polybutene, has no fluidity when at rest, but exhibits thixotropic properties. Since a mixture of a gel-like composition consisting of a thixotropic agent and a thixotropic agent is allowed to coexist with blood in a container, a centrifugation operation is performed.
First of all, the first effect is that the mixture of the chlorinated polybutene and the gel composition as described above has good fluidity, and a gel composition with excellent thixotropy can be obtained. Problems that can be observed when used alone, such as the need for time to show sufficient fluidity, the tendency to form bubbles and difficulty in defoaming, and low dispensing accuracy and poor work efficiency, etc. Not only can this be solved, but the amount of gel composition used can be reduced, so it is possible to avoid the delay in blood coagulation that occurs when there is a large amount of silicone, and furthermore, the deterioration in test accuracy that occurs when there is a large amount of silica. For example, cost can be improved by reducing the amount of liquid silicone used.
第2の作用効果としては遠心分離操作終了後に
は、分離壁おお上部層が静止時には流動性を示さ
ない上記ゲル状組成物より形成されている為、塩
素化ポリブテンを単独で使用する場合に認められ
る問題点、例えば分離後衝撃等によつて不測の力
が加わると形成されていた分離壁が破壊され易い
点、デカンテーシヨンによる血清或は血漿の円滑
な分取がむずかしい点、又、ピペツト等で吸い上
げる方式による場合も、ピペツトの先端部分に塩
素化ポリブテンが付着してピペツトの先端を汚し
たり、ピペツトの内部をつまらせたり、さらには
ピペツトを引き上げる時に糸引きを起し、スピツ
ツ管等の容器をよごしたり、血清或は血漿のなか
に混入したりするトラブルが発生し易い点等を解
決出来ることが挙げられ、又、血清或いは血漿分
離剤としてスチレンビースを用いた場合の欠点、
例えば分離壁が破壊されやすい点やビーズ粒子が
分離壁から遊離して血清若しくは血漿中に混入し
やすい点等につにても前記と同様解消されるので
ある。 The second effect is that after the centrifugation operation is completed, the separation wall and the upper layer are formed from the above-mentioned gel-like composition that does not exhibit fluidity when it is stationary. For example, the separation wall that has been formed is easily destroyed when an unexpected force is applied due to an impact after separation, it is difficult to smoothly separate serum or plasma by decantation, and there are also problems with pipettes. Even when using the suction method, chlorinated polybutene may adhere to the tip of the pipette, staining the tip of the pipette, clogging the inside of the pipette, and even causing stringiness when pulling up the pipette, causing damage to Spitz tubes, etc. It is possible to solve problems such as soiling the container or contamination with serum or plasma, and also the disadvantages of using styrene beads as a serum or plasma separation agent.
For example, problems such as the tendency of the separation wall to be destroyed and the tendency for bead particles to be released from the separation wall and mixed into serum or plasma can be solved in the same manner as described above.
次に本発明の実施例を示す。 Next, examples of the present invention will be shown.
(実施例)
比重1.08、25℃に於ける粘度が100000CPSの塩
素化ポリブテンを用意し、ゲル状組成物として
は、シリコーン流体(比重0.97のジメチルポリシ
ロキサン、米国ユニオンカーバイド社製「L―
45」)シリカ粉体(比重2.30の不定形疎水性シリ
カ微粉末、米国デグサ社製「アエロジルR972」)
を添加し十分混練することにより優れたチキソト
ロピー性を有する比重1.05の組成物を用意した。(Example) Chlorinated polybutene with a specific gravity of 1.08 and a viscosity of 100,000 CPS at 25°C was prepared, and as a gel composition, a silicone fluid (dimethylpolysiloxane with a specific gravity of 0.97, "L-
45) Silica powder (amorphous hydrophobic silica fine powder with a specific gravity of 2.30, "Aerosil R972" manufactured by Degussa, USA)
By adding and sufficiently kneading, a composition having a specific gravity of 1.05 and having excellent thixotropic properties was prepared.
次に、上記二つの組成物を、塩素化ポリブテン
3、ゲル状組成物1の容積比で混合攪拌したもの
を、全量2c.c.秤量し、あらかじめスピツツ管に採
集され静置されている血液中に加えて共存させた
状態で、2500rpm、10分間の遠心分離操作を行つ
た。遠心分離操作終了後、スピツツ管のなかは、
上部から血清、ゲル状組成物、塩素化ポリブテ
ン、血餅の順に層状に分離されており、静止した
状態では流動しないゲル状組成物よりなる分離壁
が形成されている為、血清の採取は、ピペツトに
よる吸い上げの方法では勿論のこと、デカンテー
シヨンによる方法でも、極めて円滑、かつ精度よ
く、しかも充分な収量をもつて実施出来ることを
確認出来た。 Next, the above two compositions were mixed and stirred at a volume ratio of 3 parts of the chlorinated polybutene to 1 part of the gel composition, and a total amount of 2 c.c. A centrifugation operation was performed at 2500 rpm for 10 minutes while the cells were added to the solution and allowed to coexist. After the centrifugation operation, inside the Spitz tube,
Serum, gel composition, chlorinated polybutene, and blood clot are separated into layers from the top in this order, and a separation wall made of the gel composition that does not flow in a static state is formed, so serum collection is as follows: It was confirmed that not only the method of sucking up with a pipette but also the method of decantation can be carried out extremely smoothly and accurately with sufficient yield.
Claims (1)
つて血清或いは血漿と血球とに分離する方法に於
て、比重が1.026〜1.09であり静止時に流動性を
有するが液状シリコーンと相溶性に乏しい塩素化
ポリブテンと、比重が1.026〜1.09で且つ上記塩
素化ポリブテンより小さく、静止時に流動性がな
いがチキソトロピー性を示す、液状シリコーンと
チキソトロピー性付与剤とからなるゲル状組成物
との混合物を、容器内の血液と共存させて遠心分
離操作を行うことを特徴とする血清或いは血漿分
離方法。 2 ゲル状組成物がシリコーン流体にシリカ粉体
を添加したものである特許請求の範囲第1項記載
の分離方法。 3 塩素化ポリブテンの25℃に於ける粘度が500
〜2000000CPSである特許請求の範囲第1項又は
第2項に記載の分離方法。[Claims] 1. A method for separating blood collected in a container into serum or plasma and blood cells by centrifugation, which has a specific gravity of 1.026 to 1.09 and has fluidity when at rest, but is in a liquid state. A gel-like composition consisting of chlorinated polybutene, which has poor compatibility with silicone, liquid silicone, which has a specific gravity of 1.026 to 1.09 and is smaller than the above chlorinated polybutene, and exhibits thixotropic properties although it has no fluidity at rest, and a thixotropic agent. 1. A method for separating serum or plasma, which comprises performing a centrifugal separation operation while coexisting with blood in a container. 2. The separation method according to claim 1, wherein the gel composition is a silicone fluid with silica powder added thereto. 3 The viscosity of chlorinated polybutene at 25℃ is 500
20,000,000 CPS. The separation method according to claim 1 or 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7949579A JPS564053A (en) | 1979-06-22 | 1979-06-22 | Serum or blood plasma separating method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7949579A JPS564053A (en) | 1979-06-22 | 1979-06-22 | Serum or blood plasma separating method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS564053A JPS564053A (en) | 1981-01-16 |
| JPS6129669B2 true JPS6129669B2 (en) | 1986-07-08 |
Family
ID=13691483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7949579A Granted JPS564053A (en) | 1979-06-22 | 1979-06-22 | Serum or blood plasma separating method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS564053A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4828720A (en) * | 1986-02-25 | 1989-05-09 | Mitsubishi Chemical Industries Limited | Liquid separating agent and liquid separating method |
| KR20250131842A (en) | 2017-12-27 | 2025-09-03 | 세키스이 메디칼 가부시키가이샤 | Composition for separating blood serum or blood plasma, blood collection container, and method for separating blood serum or blood plasma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3852194A (en) * | 1972-12-11 | 1974-12-03 | Corning Glass Works | Apparatus and method for fluid collection and partitioning |
| JPS5266621A (en) * | 1975-11-29 | 1977-06-02 | Terumo Corp | Serum or plasma separating composition |
| JPS592345B2 (en) * | 1978-06-20 | 1984-01-18 | マイクル、ジユリウス、リユ−カス | Device for separating whole blood samples into serum and clot parts |
-
1979
- 1979-06-22 JP JP7949579A patent/JPS564053A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS564053A (en) | 1981-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0035575B1 (en) | Blood serum-separating agent | |
| EP0039898B1 (en) | Apparatus for separating blood | |
| US5053134A (en) | Lymphocyte collection tube | |
| US4917801A (en) | Lymphocyte collection tube | |
| JPH02111374A (en) | Separation of platelet, lymphocyte and mononuclear large leucocyte | |
| US4534798A (en) | Composition for partitioning blood components | |
| AU749445B2 (en) | Additive preparation and method of use thereof | |
| EP0176080B1 (en) | Blood partitioning method and apparatus | |
| US4021340A (en) | Blood separating composition | |
| US4818418A (en) | Blood partitioning method | |
| JP5297191B2 (en) | Serum or plasma separation composition and blood test container | |
| CN114340493A (en) | Blood collection container and method for separating plasma | |
| JP3063799B2 (en) | Blood separation agent | |
| JP2550232B2 (en) | Blood separating agent | |
| CN109504599A (en) | Circulating tumor cell is concentrated and separated the concentration and separation method of equipment and circulating tumor cell | |
| EP0184274B1 (en) | Partition for a lymphocyte collection tube | |
| WO2005049168A2 (en) | Method and apparatus for pre-enrichment and recovery of cells from densified whole blood | |
| JPS6129669B2 (en) | ||
| JP7513343B2 (en) | Composition for separating mononuclear cell-containing plasma and blood collection container | |
| JPS6116023B2 (en) | ||
| JPS61154541A (en) | Vacuum blood sampling tube | |
| JPH04340465A (en) | Serum separating sealant | |
| JPS5837560A (en) | Sealant for separation of serum or plasma | |
| JPH0510095B2 (en) | ||
| AU2002300487B2 (en) | Additive preparation and method of use thereof |